Mina K. Chung, Khaldoun G. Tarakji, Ali H. Hakim, Mohamed Kanj, Amr F. Barakat, Mark Niebauer, Mohammed A. Chamsi-Pasha, Bruce D. Lindsay, Oussama M. Wazni, Andrea Natale, David O. Martin, Ayman A. Hussein, Thomas Dresing, Mandeep Bhargava, Thomas Callahan, Patrick J. Tchou, Mohammed Bassiouny, Daniel J. Cantillon, Rasha Al-Bawardy, Bryan Baranowski, Niraj Varma, and Walid Saliba
Background— Various ablation strategies of persistent atrial fibrillation (PersAF) have had disappointing outcomes, despite concerted clinical and research efforts, which could reflect progressive atrial fibrillation–related atrial remodeling. Methods and Results— Two-year outcomes were assessed in 1241 consecutive patients undergoing first-time ablation of PersAF (2005–2012). The time intervals between the first diagnosis of PersAF and the ablation procedures were determined. Patients had echocardiograms and measures of B-type natriuretic peptide and C-reactive protein before the procedures. The median diagnosis-to-ablation time was 3 years (25th–75th percentiles 1–6.5). With longer diagnosis-to-ablation time (based on quartiles), there was a significant increase in recurrence rates in addition to an increase in B-type natriuretic peptide levels ( P =0.01), C-reactive protein levels ( P P =0.03). The arrhythmia recurrence rates over 2 years were 33.6%, 52.6%, 57.1%, and 54.6% in the first, second, third, and fourth quartiles, respectively ( P categorical P P categorical Conclusions— In patients with PersAF undergoing ablation, the time interval between the first diagnosis of PersAF and the catheter ablation procedure had a strong association with the ablation outcomes, such as shorter diagnosis-to-ablation times were associated with better outcomes and in direct association with markers of atrial remodeling.